Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

Saved in:
Bibliographic Details
Published inJAMA dermatology (Chicago, Ill.) Vol. 150; no. 8; p. 901
Main Authors Pharaon, Momen, Tichet, Mélanie, Lebrun-Frénay, Christine, Tartare-Deckert, Sophie, Passeron, Thierry
Format Journal Article
LanguageEnglish
Published United States 01.08.2014
Subjects
Antibodies, Monoclonal, Humanized - pharmacology
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Cell Transformation, Neoplastic
Dermoscopy
Follow-Up Studies
Humans
Immunohistochemistry
Immunologic Factors - pharmacology
Integrin beta3 - analysis
Melanoma - chemistry
Melanoma - pathology
Multiple Sclerosis - drug therapy
Natalizumab
Nevus - chemistry
Nevus - pathology
Osteonectin - analysis
Skin Neoplasms - chemistry
Skin Neoplasms - pathology
Online AccessGet more information

Cover

More Information
ISSN:2168-6084
DOI:10.1001/jamadermatol.2013.9411